• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

暴发性心肌炎需要经皮体外心肺支持后的心脏功能长期随访

Long-term follow-up on cardiac function following fulminant myocarditis requiring percutaneous extracorporeal cardiopulmonary support.

作者信息

Ishida Kohki, Wada Hiroshi, Sakakura Kenichi, Kubo Norifumi, Ikeda Nahoko, Sugawara Yoshitaka, Ako Junya, Momomura Shin-ichi

机构信息

Division of Cardiovascular Medicine, Department of Integrated Medicine I, Saitama Medical Center, Jichi Medical University, Amanuma 1-847, Omiya, Saitama, Japan.

出版信息

Heart Vessels. 2013 Jan;28(1):86-90. doi: 10.1007/s00380-011-0211-8. Epub 2011 Dec 28.

DOI:10.1007/s00380-011-0211-8
PMID:22203407
Abstract

Fulminant myocarditis is a rapidly progressive, life-threatening disease with severe impairment of systolic left ventricle function in the acute phase. However, the long-term prognosis of patients who survive the acute phase with percutaneous extracorporeal cardiopulmonary support (PCPS) is not established. The purpose of this study was to elucidate the long-term follow-up on chronic cardiac function and long-term outcome. Twenty consecutive patients with fulminant myocarditis in the acute phase supported by PCPS were enrolled between January 1995 and March 2010. Echocardiography was performed at least three times; acute phase (within 3 days from onset), predischarge (days 3-30), and chronic phase (>6 months, 2.67 ± 2.19 years, mean ± SD). The clinical events were queried by their medical record and questionnaires. Eight patients (40%) died in the acute phase. The time course of ejection fraction (%) by echocardiography was 22.7 ± 9.8, 53.1 ± 7.2, and 57.2 ± 9.6 in acute, predischarge, and chronic phase, respectively. Diastolic dimension (mm) was 46.8 ± 7.4, 51.3 ± 2.9, and 50.4 ± 1.8, and systolic dimension (mm) was 41.4 ± 7.7, 36.8 ± 4.0, and 35.2 ± 3.3 in acute, predischarge, and chronic phase, respectively. There was no recurrence or admission related to heart failure during the follow-up period. The cardiac function of patients with fulminant myocarditis recovers rapidly during their stay in hospital. The cardiac function of predischarge patients remains unchanged in the chronic phase. The long-term survival of fulminant myocarditis appears favorable in the chronic phase.

摘要

暴发性心肌炎是一种进展迅速、危及生命的疾病,急性期左心室收缩功能严重受损。然而,经皮体外心肺支持(PCPS)治疗后急性期存活患者的长期预后尚不清楚。本研究的目的是阐明慢性心功能的长期随访情况及长期预后。1995年1月至2010年3月期间,连续纳入20例急性期接受PCPS支持的暴发性心肌炎患者。至少进行三次超声心动图检查,分别为急性期(发病后3天内)、出院前(第3 - 30天)和慢性期(>6个月,平均±标准差为2.67±2.19年)。通过病历和问卷查询临床事件。8例患者(40%)在急性期死亡。急性期、出院前和慢性期超声心动图测得的射血分数(%)的时间进程分别为22.7±9.8、53.1±7.2和57.2±9.6。急性期、出院前和慢性期的舒张末期内径(mm)分别为46.8±7.4、51.3±2.9和50.4±1.8,收缩末期内径(mm)分别为41.4±7.7、36.8±4.0和35.2±3.3。随访期间无心力衰竭复发或再入院情况。暴发性心肌炎患者的心功能在住院期间迅速恢复。出院前患者的心功能在慢性期保持不变。暴发性心肌炎患者在慢性期的长期生存率似乎较好。

相似文献

1
Long-term follow-up on cardiac function following fulminant myocarditis requiring percutaneous extracorporeal cardiopulmonary support.暴发性心肌炎需要经皮体外心肺支持后的心脏功能长期随访
Heart Vessels. 2013 Jan;28(1):86-90. doi: 10.1007/s00380-011-0211-8. Epub 2011 Dec 28.
2
Long-term prognosis of fulminant myocarditis rescued by percutaneous cardiopulmonary support device.经皮心肺支持装置救治暴发性心肌炎的长期预后
Circ J. 2004 Sep;68(9):829-33. doi: 10.1253/circj.68.829.
3
Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation.经皮体外膜肺氧合支持下暴发性心肌炎所致心源性休克患者的良好临床结局。
Eur Heart J. 2005 Oct;26(20):2185-92. doi: 10.1093/eurheartj/ehi411. Epub 2005 Jul 13.
4
Fulminant myocarditis treated with percutaneous cardiopulmonary support system (PCPS).采用经皮心肺支持系统(PCPS)治疗暴发性心肌炎。
Ann Thorac Cardiovasc Surg. 2008 Apr;14(2):75-80.
5
Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis.暴发性与非暴发性急性心肌炎的生存和左心室功能变化。
Circulation. 2017 Aug 8;136(6):529-545. doi: 10.1161/CIRCULATIONAHA.117.026386. Epub 2017 Jun 2.
6
Echocardiographic findings in fulminant and acute myocarditis.暴发性和急性心肌炎的超声心动图表现
J Am Coll Cardiol. 2000 Jul;36(1):227-32. doi: 10.1016/s0735-1097(00)00690-2.
7
[Successful management of a man with fulminant myocarditis using percutaneous cardiopulmonary support].[经皮心肺支持成功救治一名暴发性心肌炎患者]
Masui. 2005 Feb;54(2):172-6.
8
Factors and values at admission that predict a fulminant course of acute myocarditis: data from Tokyo CCU network database.预测急性心肌炎暴发性病程的入院因素及数值:来自东京重症监护病房网络数据库的数据
Heart Vessels. 2017 Aug;32(8):952-959. doi: 10.1007/s00380-017-0960-0. Epub 2017 Mar 3.
9
Successful treatment of fulminant myocarditis with mechanical circulatory support.机械循环支持成功治疗暴发性心肌炎
J Card Surg. 2008 Sep-Oct;23(5):570-2. doi: 10.1111/j.1540-8191.2007.00556.x. Epub 2008 Mar 18.
10
[Long term prognosis of fulminant myocarditis and predictors related to impaired cardiac function post discharge].[暴发性心肌炎的长期预后及出院后心功能受损的相关预测因素]
Zhonghua Xin Xue Guan Bing Za Zhi. 2022 Mar 24;50(3):263-269. doi: 10.3760/cma.j.cn112148-20211206-01056.

引用本文的文献

1
Comparison of predictors of survival among fulminant myocarditis patients undergoing veno-arterial extracorporeal membrane oxygenation in the adult and pediatric populations.成人和儿童暴发性心肌炎患者接受静脉-动脉体外膜肺氧合治疗时生存预测因素的比较。
Ann Med Surg (Lond). 2024 Oct 16;86(12):7049-7061. doi: 10.1097/MS9.0000000000002636. eCollection 2024 Dec.
2
Mechanical Circulatory Support Systems in Fulminant Myocarditis: Recent Advances and Outlook.暴发性心肌炎中的机械循环支持系统:最新进展与展望
J Clin Med. 2024 Feb 20;13(5):1197. doi: 10.3390/jcm13051197.
3
The Early Dynamic Change in Cardiac Enzymes and Renal Function Is Associated with Mortality in Patients with Fulminant Myocarditis on Extracorporeal Membrane Oxygenation: Analysis of a Single Center's Experience.

本文引用的文献

1
A novel phenylpyridazinone, T-3999, reduces the progression of autoimmune myocarditis to dilated cardiomyopathy.一种新型苯并哒嗪酮T-3999可减缓自身免疫性心肌炎向扩张型心肌病的发展。
Heart Vessels. 2011 Jan;26(1):81-90. doi: 10.1007/s00380-010-0018-z. Epub 2010 Oct 5.
2
Role of substance P in viral myocarditis in mice.P物质在小鼠病毒性心肌炎中的作用。
Heart Vessels. 2010 Jul;25(4):348-52. doi: 10.1007/s00380-009-1189-3. Epub 2010 Jul 31.
3
Successful management of fulminant myocarditis with left ventricular assist device: report of a severe case.
体外膜肺氧合支持下暴发性心肌炎患者心肌酶和肾功能的早期动态变化与死亡率的关系:单中心经验分析
Healthcare (Basel). 2022 Jun 8;10(6):1063. doi: 10.3390/healthcare10061063.
4
Fulminant myocarditis in adults: a narrative review.成人暴发性心肌炎:一篇叙述性综述。
J Geriatr Cardiol. 2022 Feb 28;19(2):137-151. doi: 10.11909/j.issn.1671-5411.2022.02.006.
5
Differences in Prognosis and Cardiac Function According to Required Percutaneous Mechanical Circulatory Support and Histological Findings in Patients With Fulminant Myocarditis: Insights From the CHANGE PUMP 2 Study.根据急性心肌炎患者所需的经皮机械循环支持和组织学发现的预后和心功能差异:来自 CHANGE PUMP 2 研究的见解。
J Am Heart Assoc. 2022 Feb 15;11(4):e023719. doi: 10.1161/JAHA.121.023719. Epub 2022 Feb 8.
6
Normalized Cardiac Structure and Function in COVID-19 Survivors Late After Recovery.新冠康复者康复后期的心脏结构和功能正常化
Front Cardiovasc Med. 2021 Nov 29;8:756790. doi: 10.3389/fcvm.2021.756790. eCollection 2021.
7
Extracorporeal Membrane Oxygenation for Fulminant Myocarditis: Increase of Cardiac Enzyme and SOFA Score Is Associated with High Mortality.体外膜肺氧合治疗暴发性心肌炎:心肌酶升高及序贯器官衰竭评估(SOFA)评分与高死亡率相关
J Clin Med. 2021 Apr 6;10(7):1526. doi: 10.3390/jcm10071526.
8
Effect of Acute Immunosuppression on Left Ventricular Recovery and Mortality in Fulminant Viral Myocarditis: A Case Series and Review of Literature.急性免疫抑制对暴发性病毒性心肌炎左心室恢复及死亡率的影响:病例系列及文献综述
CJC Open. 2020 Nov 11;3(3):292-302. doi: 10.1016/j.cjco.2020.10.017. eCollection 2021 Mar.
9
The diagnostic capability of electrocardiography on the cardiogenic shock in the patients with acute myocarditis.心电图对急性心肌炎所致心源性休克患者的诊断能力。
BMC Cardiovasc Disord. 2020 Dec 1;20(1):502. doi: 10.1186/s12872-020-01796-4.
10
Fulminant myocarditis: Characteristics, treatment, and outcomes.暴发性心肌炎:特征、治疗及预后
Anatol J Cardiol. 2018 Apr;19(4):279-286. doi: 10.14744/AnatolJCardiol.2017.8170. Epub 2018 Mar 13.
应用左心室辅助装置成功治疗暴发性心肌炎:1例重症病例报告
Ann Thorac Cardiovasc Surg. 2010 Aug;16(1):48-51.
4
Myocarditis.心肌炎
N Engl J Med. 2009 Apr 9;360(15):1526-38. doi: 10.1056/NEJMra0800028.
5
A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis.一项经活检证实的心肌炎前瞻性研究:诊断时临床及病因发病机制特征的预后相关性。
Eur Heart J. 2007 Jun;28(11):1326-33. doi: 10.1093/eurheartj/ehm076. Epub 2007 May 9.
6
Predictive factors of a fulminant course in acute myocarditis.急性心肌炎暴发性病程的预测因素
Int J Cardiol. 2006 Apr 28;109(1):142-5. doi: 10.1016/j.ijcard.2005.04.014.
7
Outcome of acute fulminant myocarditis in children.儿童急性暴发性心肌炎的预后
Heart. 2006 Sep;92(9):1269-73. doi: 10.1136/hrt.2005.078402. Epub 2006 Jan 31.
8
Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation.经皮体外膜肺氧合支持下暴发性心肌炎所致心源性休克患者的良好临床结局。
Eur Heart J. 2005 Oct;26(20):2185-92. doi: 10.1093/eurheartj/ehi411. Epub 2005 Jul 13.
9
Choice of mechanical support for fulminant myocarditis: ECMO vs. VAD?
Eur J Cardiothorac Surg. 2005 May;27(5):931-2; author reply 932. doi: 10.1016/j.ejcts.2005.01.042.
10
Long-term prognosis of fulminant myocarditis rescued by percutaneous cardiopulmonary support device.经皮心肺支持装置救治暴发性心肌炎的长期预后
Circ J. 2004 Sep;68(9):829-33. doi: 10.1253/circj.68.829.